Prof. Dr. Xin Shelley Wang | Public Health | Excellence in Research Award
Professor | MD Anderson Cancer Center | United States
Prof. Dr. Xin Shelley Wang, MD, MPH is a physician–scientist at The University of Texas MD Anderson Cancer Center and an internationally recognized leader in patient-reported outcomes, cancer symptom science, and supportive oncology. Her research has fundamentally advanced the measurement and management of cancer-related symptoms, including fatigue, pain, and symptom burden across disease stages and treatments. She is a principal developer and validator of widely adopted tools such as the MD Anderson Symptom Inventory, now used globally in clinical trials and routine care. Dr. Wang has authored 200+ peer-reviewed publications, accruing 17,492 citations (h-index 60, i10-index 139). Her highly cited work has shaped symptom assessment standards, informed clinical decision-making, and improved quality of life for cancer patients worldwide through multidisciplinary collaborations and translational impact.
17,494
60
139
Citations
h-index
i10-index
View Google Scholar Profile
View ORCID Profile
Related Highly Cited Publications
The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory
– Cancer, 1999. | Citations: 2,357
Assessing symptom distress in cancer patients: The MD Anderson Symptom Inventory
– Cancer, 2000. | Citations: 1,832
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model
– Cancer, 2003. | Citations: 691
Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure
– Journal of Neurosurgery: Spine, 2007. | Citations: 571
Prevalence and characteristics of moderate to severe fatigue in cancer patients and survivors
– Cancer, 2014. | Citations: 403